Ramsell Public Health Rx Partners With Drug Assistant to Help Clinics and Hospitals Increase Patient Access to Medications

OAKLAND, Calif.--(BUSINESS WIRE)-- Ramsell Public Health Rx, a pharmacy benefit and 340B solutions provider, today announced a partnership with Drug Assistant, a leading provider of Patient Assistance Program (PAP) management software, to help clinics and hospitals increase access to medications for patients who are unable to pay.

“As a 340B program manager, we see the increased need for PAP medications,” said Eric Flowers, CEO of Ramsell. “Our partnership with Drug Assistant will help our clients provide PAP medications to eligible patients at reduced or no cost, and fulfill our mission of serving the underserved and improving patient outcomes. Our common goal is to connect patients to the medications they need.”

Drug Assistant’s web-based software empowers healthcare providers with a cost-effective solution to automate the PAP application process and to ensure access to medications for their patients. PAP programs assist qualified patients that are uninsured, underinsured, and meet eligibility guidelines established by the pharmaceutical manufacturer to receive prescriptions for free or at a discounted rate. The Drug Assistant application reduces the financial burden by healthcare providers that are currently funding patient medications.

Ramsell helps hospitals and clinics increase access, improve outcomes and reduce costs with comprehensive solutions that maximize the value of the 340B Drug Pricing Program, which provides significant savings on medications. Ramsell applies nearly 20 years of in-depth expertise to help clinics and hospitals implement and manage this complex, regulated program. The savings generated from these programs allow healthcare facilities to increase patient services, serve more patients and improve patient outcomes.

“This is an ideal partnership, as we are both focused on increasing medication access, and we applaud Ramsell’s passion to serve the underserved,” said Brett Dennis, VP Business Development at Drug Assistant. “We admire their work and are excited that Drug Assistant can be a part of making a difference to those in the community that need it the most.”

About Ramsell

Ramsell Public Health Rx is a subsidiary of Ramsell Corporation, a company that has been creating positive outcomes for the health and safety of underserved populations since 1964. We help organizations maximize limited resources through cost-effective coordination of care and services for complex populations managed by public health programs, education and corrections. Ramsell offers highly-configurable, web-based technology solutions, services and expertise to assist our clients in connecting people to the services they need. Ramsell provides solutions for pharmacy benefit management, 340B program management, medication therapy management and correctional applications for discharge planning and community supervision. For more information, go to: www.ramsellcorp.com.

About Drug Assistant

Drug Assistant manages all manufacturers’ giveback programs including Inpatient Drug Restocking, Infusion Programs and Patient Assistance. The software helps determine eligibility, compiles and updates a database of available PAP drugs, and assists with ongoing renewals. Drug Assistant’s web-based system interfaces with existing accounting, admission and pharmacy software to better automate the process of patient assistance. Providers utilize the program to matches patients with more than 2,500 medications available in Patient Assistant Programs (PAP) offered by pharmaceutical manufacturers at reduced or no cost. Drug Assistant provides services to over 500 locations throughout the United States. For more information, go to: www.drugassistant.com.



CONTACT:

Ramsell Public Health Rx
Michael Woo, 510-587-2632
[email protected]
or
Drug Assistant
Brett Dennis, 913-322-1594
[email protected]

KEYWORDS:   United States  North America  California

INDUSTRY KEYWORDS:   Technology  Software  Health  Hospitals  Pharmaceutical  General Health

MEDIA:

Logo
 Logo

Suggested Articles

The profit margins and management of Community Health Group raise questions about oversight of managed care insurers.

Financial experts are warning practices about the pitfalls of promoting medical credit cards to their patients.

A proposed rule issued by HHS on Tuesday would expand short-term coverage, a move Seema Verma said will have "virtually no impact" on ACA premiums.